{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:27:09Z","timestamp":1794576429955,"version":"4.9.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T00:00:00Z","timestamp":1505952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.cancergen.2017.09.003","type":"journal-article","created":{"date-parts":[[2017,9,25]],"date-time":"2017-09-25T15:00:21Z","timestamp":1506351621000},"page":"58-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"special_numbering":"C","title":["Clinical testing with a panel of 25 genes associated with increased cancer risk results in a significant increase in clinically significant findings across a broad range of cancer histories"],"prefix":"10.1016","volume":"218-219","author":[{"given":"Eric T.","family":"Rosenthal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Bernhisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystal","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kidd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Manley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2017.09.003_bib0010","author":"Provenzale"},{"key":"10.1016\/j.cancergen.2017.09.003_bib0015","author":"Daly"},{"key":"10.1016\/j.cancergen.2017.09.003_bib0020","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10689-016-9883-7","article-title":"Hereditary cancer syndromes: utilizing DNA repair deficiency as therapeutic target","volume":"15","author":"Goyal","year":"2016","journal-title":"Fam Cancer"},{"key":"10.1016\/j.cancergen.2017.09.003_bib0025","author":"Myriad myRisk"},{"key":"10.1016\/j.cancergen.2017.09.003_bib0030","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12885-015-1224-y","article-title":"Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk","volume":"15","author":"Judkins","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cancergen.2017.09.003_bib0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.29010","article-title":"Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel","volume":"121","author":"Tung","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2017.09.003_bib0040","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1053\/j.gastro.2015.05.006","article-title":"Identification of a variety of mutations in cancer predisposition genes in patients with suspected Lynch syndrome","volume":"149","author":"Yurgelun","year":"2015","journal-title":"Gastroenterol"},{"key":"10.1016\/j.cancergen.2017.09.003_bib0045","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.cancergen.2017.09.003_bib0050","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/cge.12315","article-title":"A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes","volume":"86","author":"Eggington","year":"2014","journal-title":"Clin Genet"},{"key":"10.1016\/j.cancergen.2017.09.003_bib0060","author":"Daly"},{"key":"10.1016\/j.cancergen.2017.09.003_bib0065","series-title":"Genetic\/familial high-risk assessment: colorectal. NCCN clinical practice guidelines in oncology","author":"Burt","year":"2012"},{"key":"10.1016\/j.cancergen.2017.09.003_bib0070","doi-asserted-by":"crossref","first-page":"314","DOI":"10.12788\/jcso.0181","article-title":"A study of patients with ovarian cancer tested with a 25-gene hereditary cancer panel","volume":"14","author":"Langer","year":"2016","journal-title":"J Community Support Oncol"},{"key":"10.1016\/j.cancergen.2017.09.003_bib0075","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1200\/JCO.2015.65.0747","article-title":"Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of breast cancer patients","volume":"34","author":"Tung","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2017.09.003_bib0080","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1200\/JCO.2016.71.9260","article-title":"Multigene panel testing provides a new perspective on Lynch syndrome","volume":"35","author":"Espenschied","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2017.09.003_bib0085","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/GIM.0b013e3182091ba4","article-title":"Underutilization of BRCA1\/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk","volume":"13","author":"Levy","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.cancergen.2017.09.003_bib0090","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1200\/JCO.2015.66.0019","article-title":"Health care segregation, physician recommendation, and racial disparities in BRCA1\/2 testing among women with breast cancer","volume":"34","author":"McCarthy","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2017.09.003_bib0095","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ygyno.2015.08.006","article-title":"Rescreening for genetic mutations using multi-gene panel testing in patients who previously underwent non-informative genetic screening","volume":"139","author":"Frey","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cancergen.2017.09.003_bib0100","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jmoldx.2015.04.009","article-title":"A systematic comparison of traditional and multigene panel testing for hereditary breast and ovarian cancer genes in more than 1000 patients","volume":"17","author":"Lincoln","year":"2015","journal-title":"J Mol Diagn"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776217302612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776217302612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:41:58Z","timestamp":1761896518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776217302612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":18,"alternative-id":["S2210776217302612"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2017.09.003","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical testing with a panel of 25 genes associated with increased cancer risk results in a significant increase in clinically significant findings across a broad range of cancer histories","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2017.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Myriad Genetics, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}